跳至主要内容
临床试验/NCT06770751
NCT06770751招募中不适用

Family Involvement in the Intensive Care Unit: a Prospective Cohort Study Exploring Its Effects on Sedation Dosages, Delirium, Ventilator-Free Days, and Length of Stay.

Istanbul University - Cerrahpasa1 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2025年1月13日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
122
试验地点
1
主要终点
Sedative dose

研究概览

简要总结

The aim of this prospective cohort study was to investigate the effect of the time spent with relatives of patients treated in a tertiary intensive care unit on patient outcomes.

The main question it aimed to answer was:

Does spending more time with relatives of patients in intensive care result in lower sedative agent requirements? Does spending more time with relatives of patients in intensive care result in less delirium, fewer ventilator days, and shorter ICU stays?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 18 and over.
  • Patients with at least one family member actively involved in the care process in the ICU.

排除标准

  • Patients with pre-existing cognitive impairment or dementia.
  • Patients with severe traumatic brain injury.
  • Patients with an expected mortality in the ICU of more than 80%.
  • Absence of family members for patients admitted to the ICU.

结局指标

主要结局

Sedative dose

时间窗: Each patient will be evaluated and recorded daily up to first 4 weeks of their stay in ICU.

It is the average daily dose of sedative drugs used by a patient. It will be calculated for each sedative drug. It will be calculated by dividing all doses taken by the number of days of hospitalization.

次要结局

  • Delirium(Each patient will be evaluated and recorded daily up to first 4 weeks of their stay in ICU.)
  • Ventilatory days(Each patient will be evaluated and recorded daily up to first 4 weeks of their stay in ICU.)
  • Stay in intensive care unit(Each patient will be evaluated and recorded daily up to first 4 weeks of their stay in ICU.)

研究者

发起方
Istanbul University - Cerrahpasa
申办方类型
Other
责任方
Principal Investigator
主要研究者

Oguzhan Kayhan

Medical Doctor, Lecturer

Istanbul University - Cerrahpasa

研究点 (1)

Loading locations...

相似试验